Marshall Wace’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Sell
60,062
-58,749
-49% -$539K ﹤0.01% 2484
2026
Q1
$1.1M Buy
118,811
+49,133
+71% +$483K ﹤0.01% 2091
2025
Q4
$487K Sell
69,678
-38,022
-35% -$239K ﹤0.01% 2250
2025
Q3
$615K Sell
107,700
-434,791
-80% -$2.32M ﹤0.01% 2154
2025
Q2
$2.59M Buy
+542,491
New +$3.11M ﹤0.01% 1451
2024
Q4
Sell
-65,475
Closed -$1.1M 2862
2024
Q3
$1.1M Buy
65,475
+46,717
+249% +$769K ﹤0.01% 1616
2024
Q2
$293K Buy
+18,758
New +$261K ﹤0.01% 2168
2023
Q4
Sell
-134,738
Closed -$2.5M 2469
2023
Q3
$2.5M Buy
+134,738
New +$2.93M 0.01% 1125
2023
Q2
Sell
-1,148,054
Closed -$21.3M 2802
2023
Q1
$21.3M Sell
1,148,054
-528,738
-32% -$9.94M 0.05% 447
2022
Q4
$25.5M Sell
1,676,792
-1,491,122
-47% -$21.2M 0.06% 374
2022
Q3
$44.3M Buy
3,167,914
+2,954,634
+1,385% +$59.5M 0.1% 227
2022
Q2
$5.14M Buy
+213,280
New +$5.72M 0.01% 1317
2021
Q2
Sell
-53,792
Closed -$2.39M 2931
2021
Q1
$2.39M Sell
53,792
-142,472
-73% -$5.97M 0.01% 1232
2020
Q4
$7.78M Buy
196,264
+73,710
+60% +$2.74M 0.04% 419
2020
Q3
$4.79M Buy
+122,554
New +$4.69M 0.03% 529
2020
Q2
Sell
-3,358
Closed -$112K 1821
2020
Q1
$112K Buy
+3,358
New +$110K ﹤0.01% 1298
2019
Q3
Sell
-177,624
Closed -$5.52M 1849
2019
Q2
$5.52M Sell
177,624
-182,310
-51% -$5.37M 0.05% 445
2019
Q1
$10.3M Buy
359,934
+217,872
+153% +$6.59M 0.1% 252
2018
Q4
$4.05M Buy
+142,062
New +$4.44M 0.04% 511

Other funds holding NEOG

Marshall Wace's NEOG Position: Q2 2026 in Review

Marshall Wace reduced its Neogen (NEOG) stake by 49% in Q2 2026, selling an estimated $539K and leaving 60,062 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #2484.

Marshall Wace first reported a position in NEOG in Q4 2018 and has held it in 19 quarters since. The position peaked at $44.3M in Q3 2022. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Marshall Wace held 60,062 shares of Neogen worth $540K as of Q2 2026.
  • Marshall Wace sold 58,749 Neogen shares in Q2 2026, an estimated $539K.
  • Neogen made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2484 holding.
  • Marshall Wace first reported a position in Neogen in Q4 2018 and has held it in 19 quarters since.
  • Marshall Wace's Neogen position peaked at $44.3M in Q3 2022.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.